HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Chembio Diagnostics, Inc. (CEMI)
5.43  0.08  (1.5%) 08-13 01:20
Open: 5.39 High: 6.26
Pre.close: 5.35 Low: 5.21
Volume: 20,297,330 Ave vol: 5,085,853
52w High: 15.89 52w Low: 2.25
MA(50): 4.717 MA(200): 6.692
EPS: -1.171 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://chembio.com
Market Cap (M): 109
Shares Out (M): 20
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for HIV and Syphilis, and Zika virus. It also develops tests for malaria, Dengue virus, chikungunya virus, ebola, lassa, marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi. In addition, the company develops tests for a specific form of cancer, concussion, and bovine tuberculosis; and handheld optical analyzers for rapid diagnostic tests. It sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bullish
Target 1: 7.32 Target 2: 8.55
Resist 1: 6.27 Resist 2: 7.32
Support 1: 4.79 Support 2: 3.88
Company key metrics
Revenue per Share: 2.0378
Net Income per Share: -0.8086
Cash per Share: 1.0803
Book Value per Share: 1.4211
Price to Sales: 1.9629
Price to Book Value: 2.8146
Earnings Yield: -0.2021
Dividend Yield: 0
Debt to Equity: 1.3186
Debt to Assets: 0.5687
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 12 Aug 2020
Lawsuits Filed Against CEMI, CSPR and CODX - Jakubowitz Law Pursues Shareholders Claims - Yahoo Finance

Wed, 12 Aug 2020
ROSEN, A RESPECTED AND LEADING FIRM, Reminds Chembio Diagnostics, Inc. Investors of Important August 17 Deadline in Securities Class Action – CEMI - EIN News

Wed, 12 Aug 2020
Chembio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Chembio Diagnostics, Inc. To Contact The Firm - Yahoo Finance

Wed, 12 Aug 2020
CEMI DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020 - Yahoo Finance

Tue, 11 Aug 2020
Chembio Diagnostics, Inc. (CEMI): What is good about stock? - Marketing Sentinel

Sun, 09 Aug 2020
Chembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.